MORGAN CRESWELL: Open Payments
NPI 1972271559 · DALTON, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$221 in 11 payments from 9 companies in 2025. Trend: 2023 $409 · 2024 $172 · 2025 $221
Food & beverage: $221
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 3 | $50 |
| MAYNE PHARMA COMMERCIAL LLC | 1 | $35 |
| ABBVIE INC. | 1 | $22 |
| Boston Scientific Corporation | 1 | $22 |
| PFIZER INC. | 1 | $20 |
| Novo Nordisk Inc | 1 | $20 |
| SHIELD THERAPEUTICS INC | 1 | $18 |
| GlaxoSmithKline, LLC. | 1 | $18 |
| Organon LLC | 1 | $16 |
Products named: ZEPBOUND, LILETTA, General - Female SUI, PANZYGA, Wegovy, ACCRUFER, NUCALA, NEXPLANON.
Industry payments across GA — which companies pay providers there.
